Disc Medicine, Inc
Clinical trials sponsored by Disc Medicine, Inc, explained in plain language.
-
New hope for Sun-Sensitive patients: bitopertin Long-Term trial launches
Disease control ENROLLING_BY_INVITATIONThis study is for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain when skin is exposed to sunlight. The drug bitopertin is being tested to see if it can safely increase the time patients can spend in dayligh…
Phase: PHASE2, PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New drug could let Sun-Sensitive patients enjoy daylight again
Disease control OngoingThis study tests whether the drug bitopertin can safely increase the amount of time people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) can spend in sunlight without pain. About 183 participants aged 12 and older will receive either bitopertin or a pl…
Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC